The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Vania Braga's research interests include understanding the signalling pathways required for epithelial specification and how these processes are subverted during diseases and tumour progression. She is Deputy-Head of the Molecular Medicine Section, and was appointed Campus Director for the Faculty of Medicine (2012-2015). Dr. Braga participates in a number of editorial boards, review panels and grant committees in Europe.
Inserm Researcher in the field of Cardiovascular Research, currently focusing on therapeutic angiogenesis with polymer-based targeted growth factor delivery.
PhD in Tumor Biology (Pr Yihai Cao, Karolinska Institutet, Sweden), and expertise in Adipose tissue angiogenesis. Postdoc at UCLA (Pr Lily Wu) in molecular imaging and tumor lymphangiogenesis field.
Member of European Vascular Biology Organisation, French society for Cardiovascular Research, French society for Angiogenesis Research.
Paolo Brambilla is medical doctor, specialist in psychiatry, PhD in neuroscience. He has been research fellow at the University of Pittsburgh and at the University of Texas at San Antonio and adjunct Assist. Prof. of Psychiatry at the University of North Carolina. Since 2004 Dr. Brambilla is Assistant Professor of Psychiatry at the University of Udine, Italy. He co-authored more than 140 scientific peer-reviewed papers. His current lifetime h-index is 35.
Dr Vincenzo Brancaleone is Assistant Professor of Pharmacology, Dept. of Science, University of Basilicata.
He performs reviewer activity for international relevant and impacted scientific journal: Mediators of Inflammation (IF:3.263), British Journal of Pharmacology (IF:4.409), Inflammation Research (IF:2.109), Diabetes & Vascular Disease Research (IF:2.116), FasebJ (IF:5.299)
Dr. Brancaleone main research field includes: 1) vascular biology in vivo and in vitro in physiopathological conditions related to gaseous mediators: role of nitric oxide (NO) and hydrogen sulfide (H2S); 2) role of sphingosine-1-kinase/sphingosine-1-phosphate (S1PK/S1P) pathway in vascular, respiratory and inflammatory processes;
3) role of Annexin A1 and its receptor (Formylated Peptide Receptor 2, FPR2) in resolving mechanism in inflammation.
Dr. Brancaleone is full member of British Pharmacological Society (BPS) and Italian Society of Pharmacology (SIF).
Professor of Microbiology and Immunology at the School of Medicine University of North Carolina Chapel Hill. Our lab is working to understand the basic biology and pathogenesis of M. tuberculosis as a step toward developing new tuberculosis control and prevention strategies.
- Dr. rer. nat., Dept. Genetics and Neurobiology, Universität Würzburg, 2000
- PostDoc, Dept. Neurobiology & Anatomy, University of Texas, Houston Health Science Center, 2000-2003
- Independent Researcher, Institute of Biology - Neurobiology, Freie Universität Berlin, 2003-2009
- Habilitation in Zoology, Freie Universität Berlin, 2009
- Heisenberg Fellow of the DFG, Institute of Biology - Neurobiology, Freie Universität Berlin, 2009-2012
- Adjunct professor, Department of Genetics, Universität Leipzig, Apr-Sep. 2012
- Professor of Neurogenetics, Institute of Zoology, Universität Regensburg, 2012-present
PhD in Pharmacology King's College London
PDRA Developmental biology UCL
Own lab QMUL 2000.
Lab focuses on genetics of behavioural disease using zebrafish as a model system.
Professor in Bioinformatics and Genomics, Department of Molecular Biology and Biochemistry, Simon Fraser University. Michael Smith Foundation for Health Research Senior Scholar. Awards include BC Innovation and Science Council YI, Canadian Society of Microbiologists Fisher Award, Women's Executive Network - Canada's Top 100 Women, TR100 award from MIT.
I was awarded my PhD in Psychology from Warwick University in 2003. My PhD topic was language and memory in Williams syndrome. I then completed a short post-doc at Bristol Uni investigating similar issues in Down syndrome, followed by a post-doc at Oxford investigating eye-movements in autism. Since 2007 I have been a research fellow at Macquarie University. My current research uses magnetoencephalography (MEG) to investigate the neural basis of language and auditory processing in autism.
Eoin Brodie is a Senior Scientist in the Ecology Department of Berkeley Lab’s Earth and Environmental Sciences Area (EESA). Dr. Brodie serves as the Deputy Director of the Climate and Ecosystem Sciences Division, Program Domain Lead for Environmental and Biological Systems Sciences and co-lead of the labwide Microbes-to-Biomes initiative. At the University of California, Berkeley, Dr. Brodie is an Adjunct Assistant Professor in the Department of Environmental Science, Policy and Management. He obtained his Ph.D. from University College Dublin in Ireland and joined LBNL following postdoctoral research at UC Berkeley.
Lecturer and principal investigator at the School of Biosciences of the University of Birmingham, UK. Interested in eukaryotic gene expression and particularly in understanding the links between RNA processing and translation.
At present his group research focuses on understanding nonsense mediated mRNA decay (NMD) and its links with pre-mRNA splicing.
Associate Professor of Anesthesiology at University of Rochester Medical Center. PhD in Biochemistry from Cambridge University (UK) and post-doctoral training at the University of Alabama at Birmingham. Research program in mitochondria, cardiac ischemia, and cardioprotective therapies.